Binance founder CZ retweeted a Cointelegraph report about Anthropic using AI to accelerate drug development, commenting that while AI-powered drug development is "super cool," the 10-year trial/approval process will be a limiting factor. He sarcastically suggested that perhaps AI could also be used for review and approval, even potentially from competing brands. The Cointelegraph report noted that Anthropic is collaborating with six organizations to leverage its AI model Claude to accelerate drug development and has already launched a drug discovery project targeting a rare childhood muscular dystrophy.